TABLE 2.
Serotype(s) | No. of isolates | No. of STsa |
---|---|---|
6B | 44 | 11 |
19F | 30 | 16 |
23F | 26 | 6 |
14 | 17 | 5 |
6A | 14 | 7 |
15B, 15Cb | 12 | 4 |
19A | 9 | 6 |
9V | 8 | 4 |
18C | 7 | 2 |
3 | 6 | 1 |
21 | 5 | 5 |
9N | 5 | 2 |
11A | 5 | 2 |
23A | 4 | 4 |
8 | 4 | 2 |
22F | 4 | 2 |
33F | 4 | 2 |
17F | 4 | 1 |
16F | 3 | 3 |
20 | 3 | 2 |
38 | 3 | 2 |
15A | 2 | 2 |
10A | 2 | 1 |
12F | 2 | 1 |
24F | 2 | 1 |
4 | 1 | 1 |
7F | 1 | 1 |
13 | 1 | 1 |
23B | 1 | 1 |
27 | 1 | 1 |
31 | 1 | 1 |
35F | 1 | 1 |
37 | 1 | 1 |
NTc | 2 | 2 |
The total number of STs is greater than 101 as isolates of some STs were of differing serotype.
Isolates of serotypes 15B and 15C were considered together (see text).
NT, nonserotypeable.